A triglyceride-lowering effect of cattle bile is associated with elevation of cholesterol levels and liver injury in mice

Journal of Traditional Medicines

Volumn 27, Issue 4, 2010, Pages 179-185

  Watanabe, Shiro ^a   Tsuneyama, Koichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

animal bile; cholesterylesters; cholic acid; digestive medicine; transaminase

Indexed keywords

EID: 84887022062     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.27.179     Document Type: Article

References (17)

1. Feng, Y., Siu, K., Wang, N., Ng, K.M., Tsao, S.W., Nagamatsu, T. and Tong, Y.: Bear bile: dilemma of traditional medicinal use and animal protection. J. Ethnobiol. Ethnomed., 5, 2, 2009.
2. Watanabe, S., Kamei, T., Tanaka, K., Kawasuji, K., Yoshioka, T. and Ohno, M.: Roles of bile acid conjugates and phospholipids in in vitro activation of pancreatic lipase by bear bile and cattle bile. J. Ethnopharmacol., 125, 203-206, 2009.
3. Ikemoto, S., Takahashi, M., Tsunoda, N., Maruyama, K., Itakura, H., Kawanaka, K., Tabata, I., Higuchi, M. and Tange, T., Yamamoto, T., Ezaki, O.: Cholate inhibits high-fat diet-induced hyperglycemia and obesity with acyl-CoA synthetase mRNA decrease. Am. J. Physiol., 273, E37-45, 1997.
4. Watanabe, M., Houten, S.M., Wang, L., Moschetta, A., Mangelsdorf, D.J., Heyman, R.A., Moore, D.D. and Auwerx, J.: Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest., 113, 1408-1418, 2004.
5. Horoton, J.D., Goldstein, J.L. and Brown, M.S.: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest., 109, 1125-1131, 2002.
6. Uchida, K., Nomura, Y. and Takeuchi, N.: Effects of cholic acid, chenodeoxycholic acid, and their related bile acids on cholesterol, phospholipid, and bile acid levels in serum, liver, bile, and feces of rats. J. Biochem., 87, 187-194, 1980.
7. Wang, D.Q., Lammert, F., Cohen, D.E., Paigen, B. and Carey, M.C.: Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis. Am. J. Physiol., 276, G751-G760, 1999.
8. Srivastava, R.A., Averna, M., Srivastava, N. and Pape, M.E.: Dietary cholate increases plasma levels of apolipoprotein B in mice by posttranscriptional mechanisms. Int. J. Biochem. Cell Biol., 33, 1215-1226, 2001.
9. Stange, E.F., Scheibner, J. and Ditschuneit, H.: Role of primary and secondary bile acids as feedback inhibitors of bile acid synthesis in the rat in vivo. J. Clin. Invest., 84, 173-180, 1989.
10. Bertolotti, M., Abate, N., Concari, M., Guicciardi, M.E., Dilengite, M.A., Bozzoli, M., Carubbi, F. and Carulli, N.: Regulation of bile acid synthesis in humans: studies on cholesterol 7 alpha-hydroxylation in vivo. Ital. J. Gastroenterol., 27, 446-449, 1995.
11. Desai, M.S., Mariscalco, M.M., Tawil, A., Vallejo, J.G. and Smith, C.W.: Atherogenic diet-induced hepatitis is partially dependent on murine TLR4. J. Leukoc. Biol., 83, 1336-1344, 2008.
12. Jeong, W. I., Jeong, D.H., Do, S.H., Kim, Y.K., Park, H.Y., Kwon, O.D., Kim, T.H. and Jeong, K.S.: Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats. J. Vet. Med. Sci., 67, 235-242, 2005.
13. Barone, M., Francavilla, A., Polimeno, L., Ierardi, E., Romanelli, D., Berloco, P., Di, Leo, A. and Panella, C.: Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies. Hepatology, 23, 1159-1166, 1996.
14. Bligh, E.G. and Dyer, W.J.: A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 37, 911-917, 1959.
15. Araki, Y., Andoh, A., Bamba, H., Yoshikawa, K., Doi, H., Komai, Y., Higuchi, A. and Fujiyama, Y.: The cytotoxicity of hydrophobic bile acids is ameliorated by more hydrophilic bile acids in intestinal cell lines IEC-6 and Caco-2. Oncol. Rep., 10, 1931-1936, 2003.
16. Shekels, L.L., Beste, J.E. and Ho, S.B.: Tauroursodeoxycholic acid protects in vitro models of human colonic cancer cells from cytotoxic effects of hydrophobic bile acids. J. Lab. Clin. Med., 127, 57-66, 1996.
17. Fabbrini, E., Sullivan, S. and Klein, S.: Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology, 51, 679-689, 2010.